Penserra Capital Management’s Beam Therapeutics BEAM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,548	Closed	-$253K	–	1254
2023 Q3	$253K	Buy	10,548 +2,793	+36%	+$74.9K	0.01%	672
2023 Q2	$247K	Buy	7,755 +1,405	+22%	+$45.6K	﹤0.01%	723
2023 Q1	$194K	Buy	6,350 +80	+1%	+$3.16K	﹤0.01%	701
2022 Q4	$245K	Sell	6,270 -3,369	-35%	-$151K	0.01%	642
2022 Q3	$459K	Buy	9,639 +6,863	+247%	+$392K	0.01%	448
2022 Q2	$107K	Buy	2,776 +1,076	+63%	+$42.8K	﹤0.01%	758
2022 Q1	$97K	Buy	+1,700	New	+$112K	﹤0.01%	851
2021 Q4	–	Sell	-1,525	Closed	-$132K	–	1388
2021 Q3	$132K	Buy	1,525 +100	+7%	+$10K	﹤0.01%	706
2021 Q2	$183K	Buy	1,425 +115	+9%	+$9.16K	﹤0.01%	658
2021 Q1	$104K	Sell	1,310 -25	-2%	-$2.38K	﹤0.01%	677
2020 Q4	$108K	Buy	+1,335	New	+$65.7K	﹤0.01%	596